Home » Topics » BioWorld Science

BioWorld Science
RSS

Excellent anxiolytic/side effect profile described for LY-354740

Feb. 23, 1998

Reduction in brain damage with YM-872 in cat model of focal cerebral ischemia

Feb. 23, 1998

Cor Therapeutics receives milestone for Integrilin MAA review

Feb. 23, 1998

Encouraging results obtained with Hycamtin in multiple myeloma

Feb. 23, 1998

Clinical status of CS-834

Feb. 23, 1998

TAU-284 awaiting approval in Japan

Feb. 23, 1998

Controlled trial of peptide T for cognitive impairment in HIV-infected patients

Feb. 23, 1998

In vitro study shows COX-1/COX-2 inhibition not associated with anticancer activity

Feb. 23, 1998

HFE: a new therapeutic target for iron overload disorders and cancer

Feb. 23, 1998

Idec RSV antibodies covered by U.S. patents; development partners sought

Feb. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...